Enliven Therapeutics, Inc.
ELVN
$19.09
$0.351.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.62% | 7.40% | -6.58% | -2.53% | 26.61% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.81% | -9.32% | -10.10% | -14.43% | 125.19% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 0.00% | 0.00% | -99.46% | 0.00% |
| Total Current Assets | -7.48% | 7.11% | -6.64% | -5.66% | 26.69% |
|
|
|||||
| Total Current Assets | -7.48% | 7.11% | -6.64% | -5.66% | 26.69% |
| Net Property, Plant & Equipment | 130.35% | -27.30% | -20.35% | -14.39% | -12.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.31% | -8.05% | -3.96% | 74.58% | 0.00% |
| Total Assets | -7.12% | 6.66% | -6.61% | -4.59% | 26.08% |
|
|
|||||
| Total Accounts Payable | 16.39% | 31.70% | -5.91% | -60.29% | 412.59% |
| Total Accrued Expenses | -17.19% | -8.52% | 38.24% | -2.10% | -20.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -49.70% | -32.94% | -24.78% |
| Total Finance Division Other Current Liabilities | -28.43% | -5.56% | -97.72% | -9.14% | 0.79% |
| Total Other Current Liabilities | -28.43% | -5.56% | -97.72% | -9.14% | 0.79% |
| Total Current Liabilities | -12.21% | -6.53% | -22.97% | -11.69% | -3.33% |
|
|
|||||
| Total Current Liabilities | -12.21% | -6.53% | -22.97% | -11.69% | -3.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -82.35% | -49.25% |
| Total Liabilities | -10.31% | -6.53% | -22.99% | -11.79% | -3.45% |
|
|
|||||
| Common Stock & APIC | 1.28% | 8.81% | 1.24% | 1.47% | 23.67% |
| Retained Earnings | -11.72% | -10.52% | -11.75% | -11.26% | -14.72% |
| Treasury Stock & Other | -129.09% | -77.27% | 274.10% | -162.26% | -137.59% |
| Total Common Equity | -6.95% | 7.43% | -5.42% | -4.02% | 29.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.95% | 7.43% | -5.42% | -4.02% | 29.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.95% | 7.43% | -5.42% | -4.02% | 29.20% |
|
|
|||||